Ultragenyx Pharmaceutical Inc. - RARE
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 38
Latest filed: Apr 02, 2026
| Form | Count |
|---|---|
| 4 | 15 |
| 8-K | 12 |
| 144 | 8 |
| SCHEDULE 13G/A | 2 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Apr 02, 2026 | 4 | Apr 01, 2026 | 0001193125-26-140702 | View |
| Apr 02, 2026 | 8-K | Apr 02, 2026 | 0001193125-26-139084 | View |
| Apr 01, 2026 | 144 | — | 0001950047-26-003127 | View |
| Mar 30, 2026 | 8-K | Mar 30, 2026 | 0001193125-26-130498 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | — | 0000102909-26-002574 | View |
| Mar 12, 2026 | 8-K | Mar 12, 2026 | 0001193125-26-103167 | View |
| Mar 10, 2026 | 4 | Mar 06, 2026 | 0001193125-26-100309 | View |
| Mar 10, 2026 | 144 | — | 0001950047-26-002450 | View |
| Mar 06, 2026 | 144 | — | 0001950047-26-002334 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089102 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089104 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089107 | View |
| Mar 03, 2026 | 4 | Mar 02, 2026 | 0001193125-26-089109 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089111 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089278 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089282 | View |
| Mar 03, 2026 | 4 | Mar 01, 2026 | 0001193125-26-089287 | View |
| Mar 03, 2026 | 144 | — | 0001950047-26-002108 | View |
| Mar 02, 2026 | 144 | — | 0001950047-26-002038 | View |
| Feb 23, 2026 | 8-K | Feb 23, 2026 | 0001193125-26-062568 | View |
| Feb 12, 2026 | 8-K | Feb 12, 2026 | 0001193125-26-048738 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | — | 0000315066-26-000545 | View |
| Feb 03, 2026 | 8-K | Feb 03, 2026 | 0001193125-26-034474 | View |
| Feb 03, 2026 | 4 | Feb 02, 2026 | 0001193125-26-034832 | View |
| Feb 02, 2026 | 144 | — | 0001950047-26-000800 | View |
| Jan 30, 2026 | 8-K | Jan 30, 2026 | 0001193125-26-030590 | View |
| Jan 12, 2026 | 8-K | Jan 12, 2026 | 0001193125-26-009791 | View |
| Jan 05, 2026 | 4 | Jan 02, 2026 | 0001193125-26-002410 | View |
| Jan 02, 2026 | 144 | — | 0001950047-26-000020 | View |
| Dec 30, 2025 | 4 | Dec 29, 2025 | 0001193125-25-336619 | View |
| Dec 30, 2025 | 8-K | Dec 30, 2025 | 0001193125-25-337099 | View |
| Dec 29, 2025 | 8-K | Dec 29, 2025 | 0001193125-25-332422 | View |
| Dec 11, 2025 | 4 | Dec 10, 2025 | 0001193125-25-315460 | View |
| Dec 10, 2025 | 144 | — | 0001950047-25-010053 | View |
| Nov 05, 2025 | SCHEDULE 13G | — | 0000315066-25-002839 | View |
| Nov 04, 2025 | 8-K | Nov 03, 2025 | 0001193125-25-264707 | View |
| Oct 30, 2025 | 8-K | Oct 30, 2025 | 0001193125-25-257538 | View |
| Oct 14, 2025 | 4 | Oct 13, 2025 | 0001193125-25-238708 | View |